Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.525
+0.025 (1.00%)
At close: Nov 4, 2024, 4:00 PM
2.650
+0.125 (4.95%)
After-hours: Nov 4, 2024, 6:19 PM EST

Galectin Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Selling, General & Admin
5.845.946.626.365.475.97
Upgrade
Research & Development
33.8332.1331.7423.8217.987.47
Upgrade
Operating Expenses
39.6738.0738.3530.1823.4413.44
Upgrade
Operating Income
-39.67-38.07-38.35-30.18-23.44-13.44
Upgrade
Interest Expense
-4-2.79-1.03-0.49-0.09-0.09
Upgrade
Interest & Investment Income
0.30.230.0500.070.23
Upgrade
Other Non Operating Income (Expenses)
-0.91-0.430.560.14--
Upgrade
EBT Excluding Unusual Items
-44.29-41.07-38.78-30.53-23.47-13.29
Upgrade
Pretax Income
-44.29-41.07-38.78-30.53-23.47-13.29
Upgrade
Net Income
-44.29-41.07-38.78-30.53-23.47-13.29
Upgrade
Preferred Dividends & Other Adjustments
3.753.740.10.170.146.89
Upgrade
Net Income to Common
-48.03-44.81-38.87-30.7-23.6-20.18
Upgrade
Shares Outstanding (Basic)
616059595752
Upgrade
Shares Outstanding (Diluted)
616059595752
Upgrade
Shares Change (YoY)
3.32%1.29%1.48%2.63%9.17%32.54%
Upgrade
EPS (Basic)
-0.78-0.74-0.65-0.52-0.41-0.39
Upgrade
EPS (Diluted)
-0.78-0.74-0.65-0.52-0.41-0.39
Upgrade
Free Cash Flow
-32.78-32.97-31.06-24.31-20.6-10.85
Upgrade
Free Cash Flow Per Share
-0.53-0.55-0.52-0.42-0.36-0.21
Upgrade
EBIT
-39.67-38.07-38.35-30.18-23.44-13.44
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.